Reliability note

Titles and AI summaries are unofficial English monitoring aids, not legal advice or official translations. Each link opens the original Japanese official source, which remains authoritative.

MHLW announcement: unauthorized access and possible pharmaceutical system data leak

医薬品安定供給・流通確認システムへの不正アクセスに係る 個人情報の漏えいについて

Published: 2026-11-18 · Source: Ministry of Health, Labour and Welfare (MHLW) · Stage: Government Announcement · Area: Healthcare / Pharmaceuticals · Impact (preliminary): Medium · First detected by this dashboard: 2026-11-19

View the original Japanese source More Healthcare / Pharmaceuticals updates Search all updates in the dashboard

AI summary

Generated by AI from the Japanese source metadata. It is an unofficial monitoring aid, not legal advice, and may contain errors. The area, stage, and impact labels are preliminary keyword-based triage labels. Confirm every point in the original Japanese source.

Summary

On 2026-11-18, the Ministry of Health, Labour and Welfare announced unauthorized access to its pharmaceutical stable supply and distribution verification system. It identified evidence that some stored data had been viewed and attempts made to alter viewed data, with possible leakage of names and contact details of representatives at some companies; the extent of the impact remained under investigation. The maintenance contractor blocked the offending IP addresses and deleted suspicious uploaded files from the reporting system used by pharmaceutical marketing authorization holders to report supply conditions and supply concerns. The ministry announced suspension of that reporting system while investigating the access method; the information website, mainly intended for healthcare professionals, was also suspended, with reopening planned following safety checks. Pharmaceutical supply information continued to be published in Excel files on the ministry's website.

Business Impact

Pharmaceutical marketing authorization holders may face disruption to supply-status reporting, while medical institutions, pharmacies and members of the public may need an alternative source of published supply information. Representatives at some companies may have had their names and contact details exposed, although the affected population and full scope were not confirmed.

Recommended Action

Pharmaceutical marketing authorization holders could check subsequent ministry notices for reporting-system restoration and any interim reporting arrangements. Medical institutions and pharmacies could review the ministry's Excel supply-status files, while companies using the system could check whether their representatives' contact information was affected.